Clinical Trials Browser

Has results × Melanoma × TH 302 × Clear all

NCT01864538 2025-05-11

A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Phase 2 Terminated

11 enrolled 8 charts

Melanoma, Neoplasm Metastasis